Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

Bullboard (CSE:BIOV)

View:
Post by Humaniston Feb 01, 2024 4:01pm

i believe something good is coming soon,

we're up on good volume.. and some big buys.. i hope i am right . glta. 
Comment by Humaniston Feb 01, 2024 9:21am

RE:RE: I'm starting to wonder why the pvt placement hasn't closed

true, but htey already closedt with the insiders, i am wondering why the pvt one.. was expectedto closebefore or on jan 26th, it would've been nice to say when they released the nr about hte ...more  
Comment by Mario79on Jan 31, 2024 10:23pm

RE: I'm starting to wonder why the pvt placement hasn't closed

Insider Report just filed shows one of the officers participated in the private placement. Good sign that things are moving on as they said it would Let's hope for fireworks like we have never ...more  
Post by Humaniston Jan 30, 2024 11:48am

I'm starting to wonder why the pvt placement hasn't closed

and the stock price is not as strong as it used to be.. ! any thoughts or rumours.. pls share.. 
Comment by Humaniston Jan 29, 2024 9:24am

RE:BIOV EXPECTED UPDATES ( DEBT & PVT PLACEMENT)

biov announced the settlement of debt with the insiders including ceo etc.. but we're still watiting on the  we're still waiting on the below main non brokered pvt placment , i am ...more  
Post by Humaniston Jan 26, 2024 11:28am

BIOV EXPECTED UPDATES ( DEBT & PVT PLACEMENT)

BIOV SHOULD HAVE CLOSED THE DEBT WITH THE INISDERS ON JAN 19TH, AND THE PVT PLACEMENT WAS EXPECTED TO CLOSE ON OR BEFORE JAN 26TH AS PER NR BELOW . hopefully we hear something tdy that all is moving ...more  
Post by Mario79on Jan 23, 2024 6:22pm

BIOV webside

I dont what this means but when you open the website it says "Something big is in the works" I'm buying this at 6 cents tomorrow if there are any shares left. DYODD. Good luck everyone. ...more  
Post by Mario79on Jan 19, 2024 10:47am

All aboard

Fireworks show could start next week if the private placement closes and the acquisition is completed. Very few shares available for those who want to accumulate. Bud 5.5 cents and offering 6 cents ...more  
Comment by newinvestooron Jan 09, 2024 1:57pm

RE:News release. PP announced

another 55 million shares added with equal amount of warrants with a strike of .05
Post by ronnie420on Jan 09, 2024 11:46am

News release. PP announced

https://www.prnewswire.com/news-releases/biovaxys-announces-planned-private-placement-and-debt-settlement-302028880.html
Post by newinvestooron Jan 05, 2024 10:56am

New email from Biov

Sound like they fully expect to close the deal with the intellectual rights of the unnammed company We are looking forward to 2024 being an extremely exciting and transformative year for BioVaxys ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities